We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$116M
AUM Growth
-$1.44M
Cap. Flow
-$1.6M
Cap. Flow %
-1.38%
Top 10 Hldgs %
24.2%
Holding
184
New
25
Increased
26
Reduced
81
Closed
25

Top Buys

Rank Stock Value
1
VLO icon
Valero Energy
VLO
+$1.1M
2
AZN icon
AstraZeneca
AZN
+$748K
3
NVS icon
Novartis
NVS
+$704K
4
AVT icon
Avnet
AVT
+$701K
5
SYNA icon
Synaptics
SYNA
+$698K

Top Sells

Rank Stock Value
1
MLM icon
Martin Marietta Materials
MLM
+$829K
2
TD icon
Toronto Dominion Bank
TD
+$755K
3
PVTB
PrivateBancorp Inc
PVTB
+$677K
4
BMY icon
Bristol-Myers Squibb
BMY
+$664K
5
WMT icon
Walmart Inc
WMT
+$646K

Sector Composition

Rank Sector Weight
1 Healthcare 19.02%
2 Industrials 16.07%
3 Consumer Staples 15.08%
4 Financials 12.64%
5 Consumer Discretionary 12.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZTS icon
76
Zoetis
ZTS
$31.8B
$515K 0.44%
10,845
-10,400
-49% -$491K
ETN icon
77
Eaton
ETN
$174B
$505K 0.43%
8,450
-775
-8% -$47.6K
LYB icon
78
LyondellBasell Industries
LYB
$19.4B
$502K 0.43%
+6,750
New +$557K
TYL icon
79
Tyler Technologies
TYL
$12.8B
$496K 0.43%
2,976
– –
FTNT icon
80
Fortinet
FTNT
$119B
$494K 0.43%
78,125
-22,375
-22% -$145K
SYY icon
81
Sysco
SYY
$40.1B
$493K 0.42%
9,720
– –
SBUX icon
82
Starbucks
SBUX
$121B
$491K 0.42%
8,600
-1,500
-15% -$85.3K
MET icon
83
MetLife
MET
$62.4B
$486K 0.42%
13,688
– –
GIS icon
84
General Mills
GIS
$19.4B
$474K 0.41%
6,650
-1,800
-21% -$115K
MPC icon
85
Marathon Petroleum
MPC
$82.3B
$459K 0.4%
12,100
-700
-5% -$25.7K
SNA icon
86
Snap-on
SNA
$21.5B
$450K 0.39%
2,850
-300
-10% -$47.6K
WPC icon
87
W.P. Carey
WPC
$16.3B
$450K 0.39%
6,620
– –
VTRS icon
88
Viatris
VTRS
$19.4B
$439K 0.38%
10,150
-1,975
-16% -$87.4K
AVNS
89
DELISTED
Avanos Medical
AVNS
$438K 0.38%
13,457
-750
-5% -$23K
HD icon
90
Home Depot
HD
$355B
$437K 0.38%
+3,423
New +$453K
PII icon
91
Polaris
PII
$4.07B
$433K 0.37%
5,300
-300
-5% -$26.6K
COF icon
92
Capital One
COF
$134B
$429K 0.37%
6,750
-500
-7% -$34.8K
GSK icon
93
GSK
GSK
$106B
$423K 0.36%
7,800
– –
MCD icon
94
McDonald's
MCD
$196B
$423K 0.36%
3,517
– –
MXL icon
95
MaxLinear
MXL
$6.61B
$421K 0.36%
+23,400
New +$434K
BBWI icon
96
Bath & Body Works
BBWI
$4.04B
$420K 0.36%
7,731
+2,597
+51% +$152K
GOOG icon
97
Alphabet (Google) Class C
GOOG
$4.33T
$419K 0.36%
+12,100
New +$435K
NSC icon
98
Norfolk Southern
NSC
$76.2B
$417K 0.36%
4,900
-3,100
-39% -$263K
MO icon
99
Altria Group
MO
$114B
$414K 0.36%
6,000
– –
MMSI icon
100
Merit Medical Systems
MMSI
$5.28B
$413K 0.36%
+20,840
New +$401K
2 3
4
5 6

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return
FAFN
First Affirmative Financial Network Colorado Springs, Colorado $258M AUM

New England Research & Management's Q2 2016 Portfolio in Review

As of Q2 2016, New England Research & Management held 184 positions worth $116M, down 1.2% from $118M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management's Q2 2016 filing shows 25 new, 26 increased, 81 reduced and 25 closed positions. Its largest new stake was AstraZeneca: 12,875 shares worth $777K. The largest sale was Martin Marietta Materials, an estimated $829K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Staples.

  • New England Research & Management's largest Q2 2016 buy was AstraZeneca: 12,875 shares worth $777K.
  • New England Research & Management added most to Valero Energy in Q2 2016, an estimated $1.1M increase.
  • New England Research & Management's biggest Q2 2016 reduction was Bristol-Myers Squibb, cutting an estimated $664K.
  • New England Research & Management fully exited Martin Marietta Materials in Q2 2016, selling an estimated $829K.
  • New England Research & Management's ten largest holdings make up 24% of its $116M portfolio in Q2 2016.
  • New England Research & Management opened 25 new positions and closed 25 in Q2 2016.
  • New England Research & Management's portfolio value fell 1.2% quarter-over-quarter to $116M.

Based on New England Research & Management's 13F filing for Q2 2016, filed 5 Jul 2016.